ANN for Diagnosing Hepatitis Virus

Abstract: This paper presents an artificial neural network based approach for the diagnosis of hepatitis virus. A number of factors that may possibly influence the performance of patients were outlined. Such factors as age, sex, Steroid, Antivirals, Fatigue, Malaise, Anorexia, Liver Big, Liver Firm Splean Palpable, Spiders, Ascites, Varices, Bilirubin, Alk Phosphate, SGOT, Albumin, Protine and Histology, were then used as input variables for the ANN model . Test data evaluation shows that the ANN model is able to correctly predict the diagnosis of more than 93% of prospective Patients

Improving Artificial-Immune-System-based computing by exploiting intrinsic features of computer architectures

Biological systems have become highly significant for traditional computer architectures as examples of highly complex self-organizing systems that perform tasks in parallel with no centralized control. However, few researchers have compared the suitability of different computing approaches for the unique features of Artificial Immune Systems (AIS) when trying to introduce novel computing architectures, and few consider the practicality of their solutions for real world machine learning problems. We propose that the efficacy of AIS-based computing for tackling real world datasets can be improved by the exploitation of intrinsic features of computer architectures. This paper reviews and evaluates current existing implementation solutions for AIS on different computing paradigms and introduces the idea of “C Principles” and “A Principles”. Three Artificial Immune Systems implemented on different architectures are compared using these principles to examine the possibility of improving AIS through taking advantage of intrinsic hardware features

ANN for Lung Cancer Detection

In this paper, we developed an Artificial Neural Network (ANN) for detect the absence or presence of lung cancer in human body. Symptoms were used to diagnose the lung cancer, these symptoms such as Yellow fingers, Anxiety, Chronic Disease, Fatigue, Allergy, Wheezing, Coughing, Shortness of Breath, Swallowing Difficulty and Chest pain. They were used and other information about the person as input variables for our ANN. Our ANN established, trained, and validated using data set, which its title is “survey lung cancer”. Model evaluation showed that the ANN model is able to detect the absence or presence of lung cancer with 96.67 % accuracy

Breathing Signature as Vitality Score Index Created by Exercises of Qigong: Implications of Artificial Intelligence Tools Used in Traditional Chinese Medicine.

Rising concerns about the short- and long-term detrimental consequences of administration of conventional pharmacopeia are fueling the search for alternative, complementary, personalized, and comprehensive approaches to human healthcare. Qigong, a form of Traditional Chinese Medicine, represents a viable alternative approach. Here, we started with the practical, philosophical, and psychological background of Ki (in Japanese) or Qi (in Chinese) and their relationship to Qigong theory and clinical application. Noting the drawbacks of the current state of Qigong clinic, herein we propose that to manage the unique aspects of the Eastern 'non-linearity' and 'holistic' approach, it needs to be integrated with the Western "linearity" "one-direction" approach. This is done through developing the concepts of "Qigong breathing signatures," which can define our life breathing patterns associated with diseases using machine learning technology. We predict that this can be achieved by establishing an artificial intelligence (AI)-Medicine training camp of databases, which will integrate Qigong-like breathing patterns with different pathologies unique to individuals. Such an integrated connection will allow the AI-Medicine algorithm to identify breathing patterns and guide medical intervention. This unique view of potentially connecting Eastern Medicine and Western Technology can further add a novel insight to our current understanding of both Western and Eastern medicine, thereby establishing a vitality score index (VSI) that can predict the outcomes of lifestyle behaviors and medical conditions

A Clinical Prognostic Framework for Classifying Severe Liver Disorders (SLDs) and Lungs’ Vulnerability to Virus

Most severe liver diseases (SLDs) are attributed to increased risk for cancer, and cirrhosis, through which the manifestation of fibrotic tissues and scars tends to affect liver function The role of liver is indispensable, as inner organ performing services that ranges from metabolism, immune guide, energy producer and digestive aid, just to mention a few. Prevalence of classification problem and the need for automated prognosis is the continual drive to apply data mining techniques and/or machine learning algorithms in medical diagnosis and clinical support systems. Computational scientists and researchers in the field of artificial intelligence have recorded notable efforts with existing methods/models for diagnosis or prognosis, yet their effectiveness and functional performance is not without drawback due to ambiguity of medical information and selected features in patients’ data to tell the future course. In this paper, a novel hybridized machine learning model was provided (Fuzzy c-BC) for clinical classification of Severe Liver Disorders (SLDs) and to determine Lungs Vulnerability (LV) to virus; by incorporating individual strength of fuzzy cluster means (FCM) and naive Bayes classifier (NBC) for projecting future course of every categorized liver disease (LD) and its implication to aggravate lungs infection if preventive measures are not taken in timely manner

A survey on artificial intelligence based techniques for diagnosis of hepatitis variants

Hepatitis is a dreaded disease that has taken the lives of so many people over the recent past years. The research survey shows that hepatitis viral disease has five major variants referred to as Hepatitis A, B, C, D, and E. Scholars over the years have tried to find an alternative diagnostic means for hepatitis disease using artificial intelligence (AI) techniques in order to save lives. This study extensively reviewed 37 papers on AI based techniques for diagnosing core hepatitis viral disease. Results showed that Hepatitis B (30%) and C (3%) were the only types of hepatitis the AI-based techniques were used to diagnose and properly classified out of the five major types, while (67%) of the paper reviewed diagnosed hepatitis disease based on the different AI based approach but were not classified into any of the five major types. Results from the study also revealed that 18 out of the 37 papers reviewed used hybrid approach, while the remaining 19 used single AI based approach. This shows no significance in terms of technique usage in modeling intelligence into application. This study reveals furthermore a serious gap in knowledge in terms of single hepatitis type prediction or diagnosis in all the papers considered, and recommends that the future road map should be in the aspect of integrating the major hepatitis variants into a single predictive model using effective intelligent machine learning techniques in order to reduce cost of diagnosis and quick treatment of patients

Advances in Electronic-Nose Technologies Developed for Biomedical Applications

The research and development of new electronic-nose applications in the biomedical field has accelerated at a phenomenal rate over the past 25 years. Many innovative e-nose technologies have provided solutions and applications to a wide variety of complex biomedical and healthcare problems. The purposes of this review are to present a comprehensive analysis of past and recent biomedical research findings and developments of electronic-nose sensor technologies, and to identify current and future potential e-nose applications that will continue to advance the effectiveness and efficiency of biomedical treatments and healthcare services for many years. An abundance of electronic-nose applications has been developed for a variety of healthcare sectors including diagnostics, immunology, pathology, patient recovery, pharmacology, physical therapy, physiology, preventative medicine, remote healthcare, and wound and graft healing. Specific biomedical e-nose applications range from uses in biochemical testing, blood-compatibility evaluations, disease diagnoses, and drug delivery to monitoring of metabolic levels, organ dysfunctions, and patient conditions through telemedicine. This paper summarizes the major electronic-nose technologies developed for healthcare and biomedical applications since the late 1980s when electronic aroma detection technologies were first recognized to be potentially useful in providing effective solutions to problems in the healthcare industry

Studies on Real-Valued Negative Selection Algorithms for Self-Nonself Discrimination

The artificial immune system (AIS) is an emerging research field of computational intelligence that is inspired by the principle of biological immune systems. With the adaptive learning ability and a self-organization and robustness nature, the immunology based AIS algorithms have successfully been applied to solve many engineering problems in recent years, such as computer network security analysis, fault detection, and data mining. The real-valued negative selection algorithm (RNSA) is a computational model of the self/non-self discrimination process performed by the T-cells in natural immune systems. In this research, three different real-valued negative selection algorithms (i.e., the detectors with fixed radius, the V-detector with variable radius, and the proliferating detectors) are studied and their applications in data classification and bioinformatics are investigated. A comprehensive study on various parameters that are related with the performance of RNSA, such as the dimensionality of input vectors, the estimation of detector coverage, and most importantly the selection of an appropriate distance metric, is conducted and the figure of merit (FOM) of each algorithm is evaluated using real-world datasets. As a comparison, a model based on artificial neural network is also included to further demonstrate the effectiveness and advantages of RNSA for specific applications

Precision medicine in the era of artificial intelligence: implications in chronic disease management.

Aberrant metabolism is the root cause of several serious health issues, creating a huge burden to health and leading to diminished life expectancy. A dysregulated metabolism induces the secretion of several molecules which in turn trigger the inflammatory pathway. Inflammation is the natural reaction of the immune system to a variety of stimuli, such as pathogens, damaged cells, and harmful substances. Metabolically triggered inflammation, also called metaflammation or low-grade chronic inflammation, is the consequence of a synergic interaction between the host and the exposome-a combination of environmental drivers, including diet, lifestyle, pollutants and other factors throughout the life span of an individual. Various levels of chronic inflammation are associated with several lifestyle-related diseases such as diabetes, obesity, metabolic associated fatty liver disease (MAFLD), cancers, cardiovascular disorders (CVDs), autoimmune diseases, and chronic lung diseases. Chronic diseases are a growing concern worldwide, placing a heavy burden on individuals, families, governments, and health-care systems. New strategies are needed to empower communities worldwide to prevent and treat these diseases. Precision medicine provides a model for the next generation of lifestyle modification. This will capitalize on the dynamic interaction between an individual's biology, lifestyle, behavior, and environment. The aim of precision medicine is to design and improve diagnosis, therapeutics and prognostication through the use of large complex datasets that incorporate individual gene, function, and environmental variations. The implementation of high-performance computing (HPC) and artificial intelligence (AI) can predict risks with greater accuracy based on available multidimensional clinical and biological datasets. AI-powered precision medicine provides clinicians with an opportunity to specifically tailor early interventions to each individual. In this article, we discuss the strengths and limitations of existing and evolving recent, data-driven technologies, such as AI, in preventing, treating and reversing lifestyle-related diseases